What is ASGN's operating income?

ASGN's total operating income in 2025 was $230.30 million, based on the following breakdown: Total Gross Profit: $1.15 billion Total Operating Expenses: $918.80 million

ASGN (EFOR) Financials

$32.36 +0.14 (+0.43%)

As of 08/7/2026 03:54 PM Eastern

Compare

Annual Income Statements for ASGN

This table shows ASGN's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	94	95	164	155	174	200	411	266	222	170	117
Consolidated Net Income / (Loss)	98	97	158	158	175	200	410	268	219	175	114
Net Income / (Loss) Continuing Operations	71	97	158	158	150	178	232	267	219	175	114
Total Pre-Tax Income	122	157	197	204	204	242	313	364	298	240	163
Total Operating Income	152	190	225	260	276	281	351	410	364	304	230
Total Gross Profit	679	795	850	1,024	972	947	1,142	1,370	1,280	1,184	1,149
Total Revenue	2,065	2,440	2,626	3,400	3,416	3,502	4,010	4,581	4,451	4,100	3,980
Operating Revenue	2,065	2,440	2,626	3,400	3,416	3,502	4,010	4,581	4,451	4,100	3,980
Total Cost of Revenue	1,386	1,645	1,776	2,376	2,444	2,555	2,867	3,212	3,171	2,916	2,831
Operating Cost of Revenue	1,386	1,645	1,776	2,376	2,444	2,555	2,867	3,212	3,171	2,916	2,831
Total Operating Expenses	527	605	625	764	695	666	792	960	916	879	919
Selling, General & Admin Expense	492	566	592	705	645	615	736	895	844	821	854
Amortization Expense	34	40	33	59	50	51	56	65	72	58	65
Total Other Income / (Expense), net	-30	-32	-28	-56	-72	-40	-38	-46	-66	-64	-68
Interest Expense	30	32	28	56	72	40	38	46	66	64	68
Income Tax Expense	50	60	39	46	55	64	82	97	78	65	49
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	3.71	1.86	-6.50	2.70	0.70	-	-0.70	2.40	-2.70	5.00	-3.40
Basic Earnings per Share	$3.74	$1.83	$3.01	$3.02	$3.31	$3.80	$7.78	$5.30	$4.54	$3.88	$2.62
Weighted Average Basic Shares Outstanding	52.26M	53.19M	52.50M	52.30M	52.80M	52.70M	52.70M	50.60M	48.30M	45.20M	43.40M
Diluted Earnings per Share	$3.68	$1.81	$2.97	$2.98	$3.28	$3.76	$7.66	$5.23	$4.50	$3.83	$2.60
Weighted Average Diluted Shares Outstanding	53.01M	53.75M	53.20M	53.10M	53.40M	53.30M	53.50M	51.30M	48.70M	45.70M	43.60M
Weighted Average Basic & Diluted Shares Outstanding	52.20M	53.10M	52.40M	52.66M	53M	53M	51.60M	49.30M	46.50M	43.60M	41.30M

This table shows ASGN's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	52	38	49	48	35	22	32	38	26	4.80	13
Consolidated Net Income / (Loss)	50	38	47	48	42	21	29	38	25	5.50	14
Net Income / (Loss) Continuing Operations	50	38	47	48	42	21	29	38	25	5.50	14
Total Pre-Tax Income	67	53	65	63	59	31	41	51	40	11	21
Total Operating Income	83	71	80	79	74	47	60	68	56	28	41
Total Gross Profit	305	296	301	300	286	275	293	297	284	267	285
Total Revenue	1,074	1,049	1,035	1,031	985	968	1,021	1,011	980	968	1,007
Operating Revenue	1,074	1,049	1,035	1,031	985	968	1,021	1,011	980	968	1,007
Total Cost of Revenue	769	753	734	731	699	693	727	715	697	702	722
Operating Cost of Revenue	769	753	734	731	699	693	727	715	697	702	722
Total Operating Expenses	222	225	221	222	212	229	234	229	227	239	244
Selling, General & Admin Expense	204	210	206	208	198	215	217	212	211	224	226
Amortization Expense	18	15	15	14	14	14	17	17	17	15	17
Total Other Income / (Expense), net	-17	-18	-16	-16	-15	-15	-18	-17	-17	-17	-20
Interest Expense	17	18	16	16	15	15	18	17	17	17	20
Income Tax Expense	16	15	17	15	17	10	12	12	14	5.10	6.50
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-1.60	0.20	-2.10	-0.20	7.10	-0.80	-2.60	0.40	-0.40	0.70	0.80
Basic Earnings per Share	$1.08	$0.82	$1.03	$1.07	$0.96	$0.48	$0.67	$0.88	$0.59	$0.13	$0.35
Weighted Average Basic Shares Outstanding	48.30M	46.50M	45.70M	44.50M	45.20M	43.70M	43.80M	43.50M	43.40M	41.30M	41M
Diluted Earnings per Share	$1.06	$0.81	$1.02	$1.06	$0.94	$0.48	$0.67	$0.87	$0.58	$0.13	$0.35
Weighted Average Diluted Shares Outstanding	48.70M	46.90M	46.10M	45M	45.70M	44M	44M	43.70M	43.60M	41.40M	41M
Weighted Average Basic & Diluted Shares Outstanding	46.50M	45.90M	44.80M	44.20M	43.60M	43.80M	43.80M	42.70M	41.30M	41M	41M

This table details how cash moves in and out of ASGN's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-7.85	3.18	9.60	5.10	53	179	255	-459	106	29	-44
Net Cash From Operating Activities	124	199	196	287	313	425	194	308	457	400	328
Net Cash From Continuing Operating Activities	124	199	196	287	313	425	194	308	457	400	328
Net Income / (Loss) Continuing Operations	72	97	158	158	175	200	410	268	219	175	114
Consolidated Net Income / (Loss)	98	97	158	158	175	200	410	268	219	175	114
Depreciation Expense	52	62	59	95	91	90	90	91	100	96	114
Non-Cash Adjustments To Reconcile Net Income	46	41	46	50	74	38	-158	58	54	51	60
Changes in Operating Assets and Liabilities, net	-45	-1.49	-66	-15	-27	97	-148	-109	83	77	41
Net Cash From Investing Activities	-462	-22	-50	-789	-149	-219	247	-510	-41	-35	-344
Net Cash From Continuing Investing Activities	-462	-22	-50	-789	-149	-219	247	-510	-41	-35	-344
Purchase of Property, Plant & Equipment	-25	-27	-24	-29	-33	-33	-35	-38	-40	-35	-40
Acquisitions	-553	0.00	-26	-760	-116	-186	-223	-485	0.00	0.00	-304
Other Investing Activities, net	0.50	-0.85	0.10	0.20	0.00	-0.20	0.20	2.30	-0.60	0.00	0.00
Net Cash From Financing Activities	331	-174	-139	508	-111	-29	-184	-257	-311	-333	-29
Net Cash From Continuing Financing Activities	333	-174	-139	508	-111	-29	-184	-257	-311	-333	-29
Repayment of Debt	-540	-130	-108	-318	-744	-67	-1.40	-71	-610	-7.40	-286
Repurchase of Common Equity	-1.65	-41	-60	0.00	-20	-28	-181	-281	-273	-327	-170
Issuance of Debt	875	11	37	822	653	66	0.00	94	572	0.00	421
Issuance of Common Equity	6.59	9.76	7.80	9.40	13	12	14	19	19	17	14
Other Financing Activities, net	-6.65	-7.02	-15	-5.60	-12	-12	-16	-17	-18	-16	-8.60
Effect of Exchange Rate Changes	-1.47	-0.11	1.80	-1.40	-0.20	2.40	-0.60	-0.60	0.10	-2.20	1.40
Cash Interest Paid	22	27	24	51	45	38	35	44	62	63	67
Cash Income Taxes Paid	45	38	55	21	57	64	170	55	45	34	7.90

This table details how cash moves in and out of ASGN's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	30	-18	-26	34	39	-98	32	-12	35	-18	9.30
Net Cash From Operating Activities	116	73	91	136	100	17	125	84	102	19	52
Net Cash From Continuing Operating Activities	116	73	91	136	100	17	125	84	102	19	52
Net Income / (Loss) Continuing Operations	50	38	47	48	42	21	29	38	25	5.50	14
Consolidated Net Income / (Loss)	50	38	47	48	42	21	29	38	25	5.50	14
Depreciation Expense	26	25	25	23	24	26	29	29	30	28	31
Non-Cash Adjustments To Reconcile Net Income	11	15	14	12	11	20	13	13	14	17	17
Changes in Operating Assets and Liabilities, net	29	-4.10	5.50	53	23	-50	54	3.50	33	-32	-10
Net Cash From Investing Activities	-7.20	-11	-5.20	-8.00	-11	-316	-9.10	-12	-6.60	-293	-5.90
Net Cash From Continuing Investing Activities	-7.20	-11	-5.20	-8.00	-11	-316	-9.10	-12	-6.60	-293	-5.90
Purchase of Property, Plant & Equipment	-7.20	-11	-5.30	-7.90	-11	-10	-9.10	-12	-8.60	-9.40	-5.90
Net Cash From Financing Activities	-79	-80	-111	-93	-50	201	-85	-85	-61	258	-37
Net Cash From Continuing Financing Activities	-79	-80	-111	-93	-50	201	-85	-85	-61	258	-37
Repayment of Debt	-1.30	-1.30	-1.20	-1.30	-3.60	-16	-74	-143	-52	-57	-45
Repurchase of Common Equity	-75	-80	-108	-96	-44	-50	-9.50	-46	-64	-39	-12
Issuance of Debt	-	0.00	-	-	-	265	-	100	56	350	20
Other Financing Activities, net	-2.60	-8.50	-1.50	-3.70	-2.10	-5.80	-1.20	-0.80	-0.80	-3.40	-0.40
Effect of Exchange Rate Changes	0.40	0.00	-1.00	-0.50	-0.70	0.10	1.00	0.10	0.20	-0.70	0.30
Cash Interest Paid	23	9.80	22	9.60	21	9.10	24	11	23	10	26
Cash Income Taxes Paid	33	1.50	12	9.70	11	1.90	3.10	1.60	1.30	-4.00	4.00

This table presents ASGN's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,767	1,753	1,810	2,688	2,941	3,278	3,503	3,586	3,545	3,429	3,677
Total Current Assets	414	438	500	686	792	994	1,309	981	973	918	916
Cash & Equivalents	24	-	37	42	95	274	530	70	176	205	161
Accounts Receivable	355	387	429	614	649	603	708	854	742	651	674
Other Current Assets	23	17	16	19	18	17	30	17	19	62	81
Plant, Property, & Equipment, net	53	57	58	79	74	55	55	66	81	83	85
Total Noncurrent Assets	1,300	1,258	1,253	1,922	2,076	2,229	2,138	2,538	2,490	2,429	2,677
Goodwill	875	874	894	1,421	1,487	1,421	1,570	1,892	1,894	1,893	2,143
Intangible Assets	418	378	353	489	477	470	488	570	498	440	454
Other Noncurrent Operating Assets	7.07	6.96	5.75	13	113	94	81	77	98	96	80
Total Liabilities & Shareholders' Equity	1,767	1,753	1,810	2,688	2,941	3,278	3,503	3,586	3,545	3,429	3,677
Total Liabilities	983	884	819	1,506	1,565	1,691	1,637	1,684	1,653	1,652	1,873
Total Current Liabilities	160	162	167	308	341	416	451	442	394	367	424
Accounts Payable	9.13	6.27	6.87	43	39	38	20	35	34	27	47
Current Employee Benefit Liabilities	103	127	130	212	203	239	306	285	237	218	231
Other Current Liabilities	47	28	29	50	99	100	125	122	124	122	146
Total Noncurrent Liabilities	822	721	652	1,198	1,224	1,275	1,187	1,243	1,258	1,285	1,449
Long-Term Debt	756	640	575	1,100	1,032	1,033	1,034	1,067	1,037	1,034	1,169
Noncurrent Deferred & Payable Income Tax Liabilities	62	74	69	80	99	109	89	129	156	188	237
Other Noncurrent Operating Liabilities	5.12	6.59	7.37	17	93	121	64	47	66	64	42
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	785	869	991	1,182	1,376	1,587	1,865	1,901	1,892	1,777	1,804
Total Preferred & Common Equity	785	869	991	1,182	1,376	1,587	1,865	1,901	1,892	1,777	1,804
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	785	869	991	1,182	1,376	1,587	1,865	1,901	1,892	1,777	1,804
Common Stock	543	563	567	602	639	662	691	704	697	685	714
Retained Earnings	250	316	428	586	745	926	1,174	1,200	1,196	1,097	1,092
Accumulated Other Comprehensive Income / (Loss)	-8.16	-10	-3.64	-6.30	-7.00	-1.00	-0.30	-2.70	0.00	-5.00	-1.60

This table presents ASGN's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	3,525	3,561	3,579	3,489	3,451	3,432	3,698	3,715	3,700	4,028	4,024
Total Current Assets	927	972	994	933	914	907	880	916	918	970	988
Cash & Equivalents	65	94	146	158	132	167	107	139	127	144	153
Accounts Receivable	823	829	805	725	721	686	705	691	710	744	766
Other Current Assets	16	16	18	19	18	18	85	86	82	82	68
Plant, Property, & Equipment, net	72	76	79	83	79	79	80	83	83	81	79
Total Noncurrent Assets	2,527	2,513	2,506	2,473	2,458	2,445	2,799	2,715	2,699	2,976	2,957
Goodwill	1,894	1,894	1,894	1,894	1,894	1,894	2,140	2,141	2,142	2,281	2,280
Intangible Assets	552	534	516	483	468	454	504	488	471	613	596
Other Noncurrent Operating Assets	82	85	97	96	96	97	156	87	86	82	81
Total Liabilities & Shareholders' Equity	3,525	3,561	3,579	3,489	3,451	3,432	3,698	3,715	3,700	4,028	4,024
Total Liabilities	1,602	1,635	1,670	1,627	1,643	1,657	1,905	1,888	1,867	2,239	2,218
Total Current Liabilities	386	417	443	372	390	404	372	435	462	462	464
Accounts Payable	34	24	32	26	23	26	24	-	-	63	70
Current Employee Benefit Liabilities	252	267	251	233	233	237	211	246	249	251	251
Other Current Liabilities	100	126	160	113	134	141	180	189	213	148	144
Total Noncurrent Liabilities	1,216	1,218	1,227	1,256	1,253	1,254	1,578	1,454	1,405	1,777	1,754
Long-Term Debt	1,035	1,036	1,038	1,036	1,035	1,034	1,283	1,212	1,166	1,462	1,438
Noncurrent Deferred & Payable Income Tax Liabilities	129	129	131	156	156	156	191	192	192	275	275
Other Noncurrent Operating Liabilities	51	53	59	63	61	63	60	50	47	40	41
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,924	1,927	1,909	1,861	1,808	1,774	1,793	1,827	1,833	1,789	1,805
Total Preferred & Common Equity	1,924	1,927	1,909	1,861	1,808	1,774	1,793	1,827	1,833	1,789	1,805
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,924	1,927	1,909	1,861	1,808	1,774	1,793	1,827	1,833	1,789	1,805
Common Stock	715	703	702	696	688	685	719	728	728	719	726
Retained Earnings	1,210	1,224	1,208	1,165	1,123	1,091	1,078	1,101	1,107	1,073	1,082
Accumulated Other Comprehensive Income / (Loss)	-1.70	-0.30	-1.60	-0.20	-2.30	-2.10	-4.20	-1.60	-2.00	-2.30	-3.10

This table displays calculated financial ratios and metrics derived from ASGN's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.73%	18.18%	7.60%	29.47%	0.46%	2.53%	14.49%	14.26%	-2.85%	-7.88%	-2.91%
EBITDA Growth	15.69%	23.64%	12.43%	25.38%	3.43%	0.95%	18.77%	13.71%	-7.29%	-13.72%	-14.20%
EBIT Growth	10.42%	24.63%	18.43%	15.80%	6.15%	1.81%	24.79%	16.70%	-11.09%	-16.40%	-24.34%
NOPAT Growth	10.05%	31.47%	53.65%	11.84%	0.47%	2.23%	25.50%	15.82%	-10.77%	-17.19%	-27.63%
Net Income Growth	26.52%	-0.46%	62.24%	0.00%	10.78%	14.65%	104.64%	-34.59%	-18.20%	-20.11%	-35.22%
EPS Growth	29.58%	-50.82%	64.09%	0.34%	10.07%	14.63%	103.72%	-31.72%	-13.96%	-14.89%	-32.11%
Operating Cash Flow Growth	29.18%	60.69%	-1.47%	46.33%	8.98%	35.63%	-54.40%	58.91%	48.44%	-12.45%	-18.03%
Free Cash Flow Firm Growth	-431.59%	130.75%	-12.57%	-484.99%	125.46%	242.90%	-107.82%	-553.86%	281.70%	-10.43%	-112.56%
Invested Capital Growth	62.16%	-2.25%	3.22%	46.46%	3.24%	-10.28%	14.18%	22.28%	-5.00%	-5.37%	7.95%
Revenue Q/Q Growth	7.08%	1.81%	2.27%	7.96%	-10.78%	7.97%	7.46%	2.15%	-1.69%	-2.13%	-0.12%
EBITDA Q/Q Growth	6.76%	1.20%	5.17%	6.74%	-6.75%	5.73%	6.22%	-0.12%	-1.67%	-2.67%	-3.37%
EBIT Q/Q Growth	4.85%	1.60%	7.11%	5.62%	-8.39%	7.00%	8.60%	-1.23%	-1.89%	-2.93%	-7.25%
NOPAT Q/Q Growth	3.36%	3.55%	35.63%	-9.48%	-9.06%	7.15%	9.24%	-2.06%	-1.21%	-4.26%	-9.65%
Net Income Q/Q Growth	-1.15%	5.07%	37.88%	-11.98%	-3.64%	8.74%	7.78%	-9.88%	-2.36%	-4.31%	-13.16%
EPS Q/Q Growth	-1.60%	-36.49%	118.38%	-11.83%	-4.09%	8.67%	7.89%	-26.96%	45.16%	-3.04%	-12.16%
Operating Cash Flow Q/Q Growth	7.53%	10.95%	0.92%	1.98%	5.95%	1.34%	-46.62%	104.79%	9.88%	-3.89%	0.64%
Free Cash Flow Firm Q/Q Growth	-19.63%	21.37%	2.87%	0.83%	-40.05%	288.39%	-109.23%	13.67%	79.89%	-5.25%	10.99%
Invested Capital Q/Q Growth	0.13%	-1.37%	1.52%	-0.11%	2.85%	-10.84%	8.28%	5.04%	-1.71%	-1.41%	-2.09%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	32.87%	32.58%	32.37%	30.11%	28.44%	27.05%	28.49%	29.90%	28.76%	28.87%	28.87%
EBITDA Margin	9.87%	10.33%	10.79%	10.45%	10.76%	10.59%	10.99%	10.93%	10.43%	9.77%	8.64%
Operating Margin	7.37%	7.77%	8.56%	7.65%	8.09%	8.03%	8.75%	8.94%	8.18%	7.42%	5.79%
EBIT Margin	7.37%	7.77%	8.56%	7.65%	8.09%	8.03%	8.75%	8.94%	8.18%	7.42%	5.79%
Profit (Net Income) Margin	4.73%	3.98%	6.01%	4.64%	5.11%	5.72%	10.22%	5.85%	4.93%	4.27%	2.85%
Tax Burden Percent	80.10%	61.75%	80.01%	77.23%	85.47%	82.94%	130.79%	73.73%	73.66%	72.97%	69.80%
Interest Burden Percent	80.08%	82.96%	87.72%	78.48%	74.00%	85.88%	89.31%	88.79%	81.76%	78.88%	70.60%
Effective Tax Rate	41.42%	38.25%	19.89%	22.62%	26.76%	26.46%	26.04%	26.60%	26.34%	27.03%	30.20%
Return on Invested Capital (ROIC)	7.27%	7.81%	11.95%	10.68%	8.88%	9.42%	11.68%	11.41%	9.49%	8.29%	5.94%
ROIC Less NNEP Spread (ROIC-NNEP)	8.92%	4.85%	8.08%	5.22%	6.12%	8.51%	41.97%	7.08%	4.23%	2.74%	0.79%
Return on Net Nonoperating Assets (RNNOA)	6.49%	3.94%	5.00%	3.83%	4.77%	4.09%	12.07%	2.82%	2.07%	1.26%	0.40%
Return on Equity (ROE)	13.76%	11.76%	16.95%	14.51%	13.66%	13.52%	23.75%	14.24%	11.56%	9.55%	6.34%
Cash Return on Invested Capital (CROIC)	-40.15%	10.09%	8.79%	-27.02%	5.70%	20.27%	-1.56%	-8.63%	14.62%	13.81%	-1.71%
Operating Return on Assets (OROA)	10.08%	10.78%	12.61%	11.57%	9.81%	9.04%	10.35%	11.55%	10.21%	8.73%	6.48%
Return on Assets (ROA)	6.47%	5.52%	8.85%	7.01%	6.21%	6.44%	12.09%	7.56%	6.15%	5.02%	3.19%
Return on Common Equity (ROCE)	13.76%	11.76%	16.95%	14.51%	13.66%	13.52%	23.75%	14.24%	11.56%	9.55%	6.34%
Return on Equity Simple (ROE_SIMPLE)	12.44%	11.19%	15.91%	13.34%	12.69%	12.62%	21.97%	14.10%	11.59%	9.86%	0.00%
Net Operating Profit after Tax (NOPAT)	89	117	180	201	202	207	260	301	268	222	161
NOPAT Margin	4.32%	4.80%	6.85%	5.92%	5.92%	5.90%	6.47%	6.56%	6.03%	5.42%	4.04%
Net Nonoperating Expense Percent (NNEP)	-1.65%	2.97%	3.87%	5.46%	2.76%	0.91%	-30.30%	4.33%	5.27%	5.56%	5.15%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	10.13%	9.16%	7.90%	5.41%
Cost of Revenue to Revenue	67.13%	67.42%	67.63%	69.89%	71.56%	72.95%	71.51%	70.10%	71.24%	71.13%	71.13%
SG&A Expenses to Revenue	23.83%	23.19%	22.54%	20.74%	18.88%	17.56%	18.35%	19.54%	18.97%	20.03%	21.46%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.50%	24.81%	23.82%	22.46%	20.36%	19.02%	19.74%	20.96%	20.58%	21.45%	23.08%
Earnings before Interest and Taxes (EBIT)	152	190	225	260	276	281	351	410	364	304	230
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	204	252	283	355	367	371	441	501	464	401	344
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.02	2.69	3.37	2.42	2.72	2.78	3.45	2.14	2.40	2.07	1.14
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.15	0.96	1.27	0.84	1.10	1.26	1.60	0.89	1.02	0.90	0.52
Price to Earnings (P/E)	25.23	24.52	20.36	18.45	21.54	22.06	15.66	15.30	20.45	21.64	17.60
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.96%	4.08%	4.91%	5.42%	4.64%	4.53%	6.39%	6.53%	4.89%	4.62%	5.68%
Enterprise Value to Invested Capital (EV/IC)	2.05	1.99	2.54	1.75	2.02	2.49	2.93	1.75	1.96	1.73	1.09
Enterprise Value to Revenue (EV/Rev)	1.50	1.21	1.48	1.15	1.37	1.48	1.73	1.11	1.21	1.10	0.77
Enterprise Value to EBITDA (EV/EBITDA)	15.24	11.71	13.70	11.03	12.75	13.96	15.74	10.11	11.63	11.26	8.92
Enterprise Value to EBIT (EV/EBIT)	20.40	15.55	17.27	15.06	16.96	18.41	19.76	12.36	14.83	14.82	13.31
Enterprise Value to NOPAT (EV/NOPAT)	34.84	25.19	21.56	19.46	23.16	25.04	26.71	16.84	20.13	20.31	19.07
Enterprise Value to Operating Cash Flow (EV/OCF)	25.03	14.80	19.76	13.63	14.96	12.19	35.79	16.45	11.82	11.28	9.35
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	19.50	29.33	0.00	36.12	11.64	0.00	0.00	13.07	12.20	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.96	0.74	0.58	0.93	0.75	0.65	0.55	0.56	0.55	0.58	0.65
Long-Term Debt to Equity	0.96	0.74	0.58	0.93	0.75	0.65	0.55	0.56	0.55	0.58	0.65
Financial Leverage	0.73	0.81	0.62	0.73	0.78	0.48	0.29	0.40	0.49	0.46	0.51
Leverage Ratio	2.13	2.13	1.92	2.07	2.20	2.10	1.96	1.88	1.88	1.90	1.98
Compound Leverage Factor	1.70	1.77	1.68	1.62	1.63	1.80	1.75	1.67	1.54	1.50	1.40
Debt to Total Capital	49.05%	42.43%	36.72%	48.21%	42.86%	39.44%	35.66%	35.94%	35.39%	36.78%	39.33%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	49.05%	42.43%	36.72%	48.21%	42.86%	39.44%	35.66%	35.94%	35.39%	36.78%	39.33%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	50.95%	57.57%	63.28%	51.79%	57.14%	60.56%	64.34%	64.06%	64.61%	63.22%	60.67%
Debt to EBITDA	3.71	2.54	2.03	3.10	2.81	2.79	2.35	2.13	2.23	2.58	3.40
Net Debt to EBITDA	3.59	2.43	1.90	2.98	2.55	2.05	1.14	1.99	1.85	2.07	2.93
Long-Term Debt to EBITDA	3.71	2.54	2.03	3.10	2.81	2.79	2.35	2.13	2.23	2.58	3.40
Debt to NOPAT	8.48	5.47	3.20	5.47	5.10	5.00	3.98	3.55	3.86	4.65	7.27
Net Debt to NOPAT	8.21	5.23	2.99	5.26	4.63	3.67	1.94	3.31	3.21	3.73	6.27
Long-Term Debt to NOPAT	8.48	5.47	3.20	5.47	5.10	5.00	3.98	3.55	3.86	4.65	7.27
Altman Z-Score	3.27	3.78	4.86	3.20	3.45	3.53	4.59	3.75	3.91	3.47	2.52
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.58	2.69	3.00	2.23	2.32	2.39	2.90	2.22	2.47	2.50	2.16
Quick Ratio	2.36	2.38	2.79	2.13	2.18	2.11	2.75	2.09	2.33	2.33	1.97
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-492	151	132	-509	130	445	-35	-227	413	370	-46
Operating Cash Flow to CapEx	502.43%	734.51%	808.23%	1,001.39%	957.80%	1,303.07%	558.21%	820.80%	1,145.11%	1,133.14%	823.87%
Free Cash Flow to Firm to Interest Expense	-16.30	4.68	4.79	-9.10	1.81	11.20	-0.93	-4.95	6.22	5.75	-0.69
Operating Cash Flow to Interest Expense	4.11	6.17	7.12	5.13	4.36	10.70	5.17	6.71	6.88	6.22	4.84
Operating Cash Flow Less CapEx to Interest Expense	3.29	5.33	6.24	4.62	3.91	9.88	4.24	5.89	6.28	5.67	4.26
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.37	1.39	1.47	1.51	1.21	1.13	1.18	1.29	1.25	1.18	1.12
Accounts Receivable Turnover	6.54	6.58	6.44	6.52	5.41	5.60	6.12	5.87	5.58	5.89	6.01
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	42.36	44.32	45.69	49.60	44.71	54.47	72.97	75.53	60.27	50.00	47.64
Accounts Payable Turnover	162.54	213.69	270.39	95.10	59.39	65.93	98.19	116.15	91.64	95.29	76.11
Days Sales Outstanding (DSO)	55.85	55.46	56.67	55.95	67.46	65.22	59.67	62.22	65.41	61.98	60.76
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	2.25	1.71	1.35	3.84	6.15	5.54	3.72	3.14	3.98	3.83	4.80
Cash Conversion Cycle (CCC)	53.60	53.76	55.32	52.11	61.31	59.68	55.96	59.08	61.43	58.15	55.96
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,516	1,482	1,530	2,241	2,313	2,075	2,370	2,898	2,753	2,605	2,812
Invested Capital Turnover	1.68	1.63	1.74	1.80	1.50	1.60	1.80	1.74	1.58	1.53	1.47
Increase / (Decrease) in Invested Capital	581	-34	48	711	73	-238	294	528	-145	-148	207
Enterprise Value (EV)	3,105	2,951	3,882	3,919	4,684	5,178	6,933	5,062	5,400	4,512	3,065
Market Capitalization	2,373	2,338	3,343	2,860	3,747	4,419	6,429	4,066	4,539	3,684	2,057
Book Value per Share	$14.86	$16.41	$19.06	$22.53	$26.06	$30.00	$35.80	$38.10	$40.09	$40.20	$42.25
Tangible Book Value per Share	($9.62)	($7.22)	($4.91)	($13.87)	($11.12)	($5.74)	($3.69)	($11.23)	($10.59)	($12.58)	($18.57)
Total Capital	1,540	1,509	1,567	2,283	2,409	2,621	2,899	2,968	2,929	2,810	2,973
Total Debt	756	640	575	1,100	1,032	1,033	1,034	1,067	1,037	1,034	1,169
Total Long-Term Debt	756	640	575	1,100	1,032	1,033	1,034	1,067	1,037	1,034	1,169
Net Debt	732	613	539	1,059	937	759	504	996	861	828	1,008
Capital Expenditures (CapEx)	25	27	24	29	33	33	35	38	40	35	40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	230	248	296	336	355	304	329	469	403	345	331
Debt-free Net Working Capital (DFNWC)	254	275	333	378	451	578	859	539	579	551	492
Net Working Capital (NWC)	254	275	333	378	451	578	859	539	579	551	492
Net Nonoperating Expense (NNE)	-8.54	20	22	44	28	6.50	-150	32	49	47	47
Net Nonoperating Obligations (NNO)	732	613	539	1,059	937	488	504	996	861	828	1,008
Total Depreciation and Amortization (D&A)	52	62	59	95	91	90	90	91	100	96	114
Debt-free, Cash-free Net Working Capital to Revenue	11.14%	10.16%	11.28%	9.89%	10.41%	8.67%	8.20%	10.24%	9.06%	8.43%	8.31%
Debt-free Net Working Capital to Revenue	12.29%	11.27%	12.67%	11.12%	13.19%	16.51%	21.41%	11.77%	13.01%	13.43%	12.36%
Net Working Capital to Revenue	12.29%	11.27%	12.67%	11.12%	13.19%	16.51%	21.41%	11.77%	13.01%	13.43%	12.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.74	$3.66	$6.02	$3.02	$3.31	$3.80	$7.78	$5.30	$4.54	$3.88	$2.62
Adjusted Weighted Average Basic Shares Outstanding	52.26M	53.19M	52.50M	52.33M	52.80M	52.70M	52.70M	50.60M	48.30M	45.20M	43.40M
Adjusted Diluted Earnings per Share	$3.68	$3.62	$5.94	$2.98	$3.28	$3.76	$7.66	$5.23	$4.50	$3.83	$2.60
Adjusted Weighted Average Diluted Shares Outstanding	53.01M	53.75M	53.21M	53.06M	53.40M	53.30M	53.50M	51.30M	48.70M	45.70M	43.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.20M	52.65M	52.18M	52.66M	53M	53M	51.60M	49.30M	46.50M	43.60M	41.30M
Normalized Net Operating Profit after Tax (NOPAT)	89	117	180	201	202	207	260	301	268	222	161
Normalized NOPAT Margin	4.32%	4.80%	6.85%	5.92%	5.92%	5.90%	6.47%	6.56%	6.03%	5.42%	4.04%
Pre Tax Income Margin	5.90%	6.45%	7.51%	6.01%	5.98%	6.90%	7.82%	7.94%	6.69%	5.86%	4.09%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.04	5.87	8.14	4.65	3.85	7.08	9.36	8.92	5.48	4.73	3.40
NOPAT to Interest Expense	2.95	3.62	6.52	3.60	2.82	5.21	6.92	6.55	4.04	3.45	2.37
EBIT Less CapEx to Interest Expense	4.22	5.03	7.26	4.13	3.39	6.26	8.43	8.10	4.88	4.19	2.81
NOPAT Less CapEx to Interest Expense	2.13	2.78	5.64	3.08	2.36	4.39	6.00	5.73	3.44	2.91	1.79
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	17.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	1.68%	59.58%	38.11%	0.00%	11.45%	13.93%	44.23%	104.96%	124.53%	186.76%	149.87%

This table displays calculated financial ratios and metrics derived from ASGN's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	41,300,000.00	41,000,000.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	41,300,000.00	41,000,000.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.12	0.33
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.63%	-7.07%	-8.51%	-7.68%	-8.30%	-7.69%	-1.36%	-1.90%	-0.50%	0.00%	-1.33%
EBITDA Growth	-6.75%	-12.56%	-14.58%	-17.10%	-10.08%	-24.32%	-15.82%	-4.99%	-12.23%	-22.85%	-18.12%
EBIT Growth	-7.74%	-15.80%	-17.88%	-19.98%	-11.03%	-34.27%	-25.87%	-13.94%	-24.26%	-40.56%	-31.04%
NOPAT Growth	-4.90%	-16.34%	-18.03%	-18.51%	-15.65%	-38.41%	-28.20%	-14.02%	-32.42%	-53.96%	-33.16%
Net Income Growth	-9.53%	-23.03%	-21.46%	-20.03%	-15.71%	-45.14%	-37.92%	-19.79%	-40.57%	-73.68%	-51.54%
EPS Growth	411.76%	-18.18%	-16.39%	-13.82%	-11.32%	-40.74%	-34.31%	-17.92%	-38.30%	-72.92%	-47.76%
Operating Cash Flow Growth	54.58%	-8.94%	-19.38%	-7.93%	-13.92%	-77.08%	37.71%	-38.22%	2.10%	10.12%	-58.21%
Free Cash Flow Firm Growth	144.98%	147.48%	154.47%	598.23%	-3.29%	-237.32%	-167.70%	-182.06%	-185.31%	85.45%	-11.06%
Invested Capital Growth	-5.00%	-5.34%	-5.49%	-5.66%	-5.37%	11.43%	6.95%	8.71%	7.95%	1.82%	6.58%
Revenue Q/Q Growth	-3.82%	-2.34%	-1.36%	-0.36%	-4.46%	-1.70%	5.40%	-0.90%	-3.09%	-1.20%	4.00%
EBITDA Q/Q Growth	-11.59%	-12.56%	9.96%	-2.48%	-4.11%	-26.40%	22.30%	10.08%	-11.42%	-35.31%	29.80%
EBIT Q/Q Growth	-15.42%	-14.99%	13.40%	-1.87%	-5.96%	-37.20%	27.90%	13.93%	-17.23%	-50.71%	48.38%
NOPAT Q/Q Growth	-13.98%	-19.42%	15.91%	1.43%	-10.96%	-41.16%	35.13%	21.45%	-30.01%	-59.91%	96.17%
Net Income Q/Q Growth	-15.32%	-24.25%	23.88%	0.64%	-10.74%	-50.71%	40.19%	30.03%	-33.86%	-78.17%	158.18%
EPS Q/Q Growth	-13.82%	576.47%	25.93%	3.92%	-11.32%	-48.94%	39.58%	29.85%	-33.33%	-77.59%	169.23%
Operating Cash Flow Q/Q Growth	-21.08%	-37.03%	23.74%	49.72%	-26.22%	-83.23%	643.45%	-32.83%	21.93%	-81.92%	182.16%
Free Cash Flow Firm Q/Q Growth	565.28%	-1.16%	5.29%	0.85%	-7.86%	-240.34%	48.09%	-22.25%	4.21%	76.06%	-296.09%
Invested Capital Q/Q Growth	-1.71%	-0.49%	-1.03%	-2.54%	-1.41%	17.17%	-5.01%	-0.94%	-2.09%	10.51%	-0.56%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.39%	28.24%	29.10%	29.14%	29.04%	28.44%	28.74%	29.36%	28.93%	27.53%	28.26%
EBITDA Margin	10.16%	9.09%	10.14%	9.92%	9.96%	7.46%	8.65%	9.61%	8.78%	5.75%	7.18%
Operating Margin	7.76%	6.76%	7.77%	7.65%	7.53%	4.81%	5.84%	6.71%	5.73%	2.86%	4.08%
EBIT Margin	7.76%	6.76%	7.77%	7.65%	7.53%	4.81%	5.84%	6.71%	5.73%	2.86%	4.08%
Profit (Net Income) Margin	4.68%	3.63%	4.56%	4.61%	4.30%	2.16%	2.87%	3.77%	2.57%	0.57%	1.41%
Tax Burden Percent	75.41%	71.48%	73.07%	75.52%	71.50%	66.99%	70.77%	75.45%	63.80%	51.89%	68.60%
Interest Burden Percent	79.98%	75.18%	80.35%	79.72%	79.92%	66.95%	69.46%	74.37%	70.28%	38.27%	50.37%
Effective Tax Rate	24.59%	28.52%	26.94%	24.48%	28.50%	33.01%	29.23%	24.55%	36.20%	48.11%	31.40%
Return on Invested Capital (ROIC)	9.22%	7.50%	8.70%	8.90%	8.24%	4.47%	5.90%	7.32%	5.38%	1.92%	3.71%
ROIC Less NNEP Spread (ROIC-NNEP)	7.87%	6.14%	7.45%	7.52%	6.98%	3.51%	4.60%	5.94%	4.22%	1.23%	2.52%
Return on Net Nonoperating Assets (RNNOA)	3.85%	3.00%	3.68%	3.59%	3.21%	2.05%	2.50%	3.14%	2.16%	0.88%	1.64%
Return on Equity (ROE)	13.08%	10.49%	12.38%	12.49%	11.46%	6.53%	8.40%	10.46%	7.54%	2.80%	5.35%
Cash Return on Invested Capital (CROIC)	14.62%	14.66%	14.44%	14.35%	13.81%	-3.80%	-0.07%	-1.89%	-1.71%	2.94%	-1.96%
Operating Return on Assets (OROA)	9.69%	8.42%	9.47%	9.15%	8.86%	5.38%	6.53%	7.50%	6.42%	2.95%	4.18%
Return on Assets (ROA)	5.85%	4.53%	5.56%	5.51%	5.06%	2.41%	3.21%	4.21%	2.88%	0.59%	1.45%
Return on Common Equity (ROCE)	13.08%	10.49%	12.38%	12.49%	11.46%	6.53%	8.40%	10.46%	7.54%	2.80%	5.35%
Return on Equity Simple (ROE_SIMPLE)	0.00%	11.17%	10.79%	10.32%	0.00%	8.81%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	63	51	59	60	53	31	42	51	36	14	28
NOPAT Margin	5.86%	4.83%	5.68%	5.78%	5.39%	3.22%	4.13%	5.07%	3.66%	1.48%	2.80%
Net Nonoperating Expense Percent (NNEP)	1.36%	1.36%	1.25%	1.37%	1.26%	0.97%	1.30%	1.38%	1.16%	0.69%	1.19%
Return On Investment Capital (ROIC_SIMPLE)	2.15%	-	-	-	1.89%	1.00%	1.39%	1.71%	1.21%	0.44%	0.87%
Cost of Revenue to Revenue	71.61%	71.76%	70.90%	70.86%	70.96%	71.56%	71.26%	70.64%	71.07%	72.47%	71.74%
SG&A Expenses to Revenue	18.96%	20.04%	19.87%	20.13%	20.09%	22.15%	21.24%	20.98%	21.48%	23.17%	22.46%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	20.62%	21.48%	21.33%	21.48%	21.50%	23.63%	22.90%	22.64%	23.19%	24.67%	24.18%
Earnings before Interest and Taxes (EBIT)	83	71	80	79	74	47	60	68	56	28	41
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	109	95	105	102	98	72	88	97	86	56	72
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.40	2.66	2.24	2.35	2.07	1.53	1.20	1.13	1.14	0.89	0.41
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.02	1.13	0.95	1.00	0.90	0.68	0.55	0.52	0.52	0.40	0.18
Price to Earnings (P/E)	20.45	23.61	20.52	22.36	21.64	17.84	16.01	16.38	17.60	15.99	8.99
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.89%	4.23%	4.87%	4.47%	4.62%	5.60%	6.25%	6.10%	5.68%	6.26%	11.12%
Enterprise Value to Invested Capital (EV/IC)	1.96	2.13	1.83	1.91	1.73	1.30	1.12	1.08	1.09	0.94	0.65
Enterprise Value to Revenue (EV/Rev)	1.21	1.33	1.16	1.20	1.10	0.99	0.81	0.78	0.77	0.73	0.51
Enterprise Value to EBITDA (EV/EBITDA)	11.63	12.92	11.44	12.25	11.26	10.51	9.03	8.75	8.92	8.91	6.48
Enterprise Value to EBIT (EV/EBIT)	14.83	16.60	14.85	16.09	14.82	14.17	12.57	12.54	13.31	13.80	10.46
Enterprise Value to NOPAT (EV/NOPAT)	20.13	22.53	20.16	21.74	20.31	19.55	17.48	17.50	19.07	19.98	15.29
Enterprise Value to Operating Cash Flow (EV/OCF)	11.82	12.95	11.57	12.12	11.28	11.55	8.63	9.56	9.35	8.85	7.85
Enterprise Value to Free Cash Flow (EV/FCFF)	13.07	14.10	12.29	12.92	12.20	0.00	0.00	0.00	0.00	32.18	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.55	0.56	0.57	0.58	0.58	0.74	0.66	0.64	0.65	0.82	0.80
Long-Term Debt to Equity	0.55	0.56	0.57	0.58	0.58	0.74	0.66	0.64	0.65	0.82	0.80
Financial Leverage	0.49	0.49	0.49	0.48	0.46	0.58	0.54	0.53	0.51	0.72	0.65
Leverage Ratio	1.88	1.85	1.88	1.90	1.90	1.97	1.97	1.98	1.98	2.16	2.13
Compound Leverage Factor	1.50	1.39	1.51	1.52	1.52	1.32	1.37	1.47	1.39	0.83	1.07
Debt to Total Capital	35.39%	35.76%	36.42%	36.83%	36.78%	42.53%	39.88%	38.87%	39.33%	44.97%	44.34%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	35.39%	35.76%	36.42%	36.83%	36.78%	42.53%	39.88%	38.87%	39.33%	44.97%	44.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	64.61%	64.24%	63.58%	63.17%	63.22%	57.47%	60.12%	61.13%	60.67%	55.03%	55.66%
Debt to EBITDA	2.23	2.30	2.39	2.51	2.58	3.52	3.36	3.28	3.40	4.47	4.62
Net Debt to EBITDA	1.85	1.95	2.09	2.11	2.07	3.23	2.97	2.92	2.93	4.03	4.13
Long-Term Debt to EBITDA	2.23	2.30	2.39	2.51	2.58	3.52	3.36	3.28	3.40	4.47	4.62
Debt to NOPAT	3.86	4.01	4.22	4.46	4.65	6.54	6.50	6.55	7.27	10.01	10.90
Net Debt to NOPAT	3.21	3.40	3.68	3.74	3.73	6.01	5.75	5.84	6.27	9.03	9.74
Long-Term Debt to NOPAT	3.86	4.01	4.22	4.46	4.65	6.54	6.50	6.55	7.27	10.01	10.90
Altman Z-Score	3.65	3.80	3.43	3.43	3.25	2.57	2.40	2.37	2.37	1.96	1.75
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.47	2.51	2.34	2.25	2.50	2.37	2.11	1.99	2.16	2.10	2.13
Quick Ratio	2.33	2.38	2.19	2.11	2.33	2.19	1.91	1.81	1.97	1.92	1.98
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	208	205	216	218	201	-282	-146	-179	-171	-41	-163
Operating Cash Flow to CapEx	1,616.67%	678.70%	1,711.32%	1,718.99%	886.73%	164.71%	1,372.53%	705.04%	1,189.53%	196.81%	884.75%
Free Cash Flow to Firm to Interest Expense	12.44	11.66	13.68	13.62	13.48	-18.30	-8.04	-10.28	-10.26	-2.40	-7.97
Operating Cash Flow to Interest Expense	6.97	4.16	5.74	8.49	6.72	1.09	6.86	4.82	6.13	1.08	2.56
Operating Cash Flow Less CapEx to Interest Expense	6.54	3.55	5.41	7.99	5.97	0.43	6.36	4.14	5.61	0.53	2.27
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.25	1.25	1.22	1.20	1.18	1.12	1.12	1.12	1.12	1.03	1.03
Accounts Receivable Turnover	5.58	5.65	5.51	5.62	5.89	5.62	5.67	5.71	6.01	5.49	5.44
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	60.27	56.51	55.09	53.09	50.00	49.43	49.32	49.11	47.64	49.48	48.88
Accounts Payable Turnover	91.64	104.21	129.79	103.15	95.29	113.79	0.00	0.00	76.11	65.07	0.00
Days Sales Outstanding (DSO)	65.41	64.64	66.19	64.96	61.98	64.96	64.38	63.96	60.76	66.47	67.06
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	3.98	3.50	2.81	3.54	3.83	3.21	0.00	0.00	4.80	5.61	0.00
Cash Conversion Cycle (CCC)	61.43	61.14	63.38	61.42	58.15	61.75	64.38	63.96	55.96	60.86	67.06
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,753	2,739	2,711	2,642	2,605	3,052	2,900	2,872	2,812	3,108	3,090
Invested Capital Turnover	1.58	1.55	1.53	1.54	1.53	1.39	1.43	1.45	1.47	1.29	1.32
Increase / (Decrease) in Invested Capital	-145	-155	-157	-158	-148	313	189	230	207	55	191
Enterprise Value (EV)	5,400	5,823	4,950	5,045	4,512	3,968	3,260	3,113	3,065	2,917	2,018
Market Capitalization	4,539	4,945	4,047	4,177	3,684	2,748	2,187	2,074	2,057	1,599	733
Book Value per Share	$40.09	$40.03	$39.39	$39.61	$40.20	$41.13	$41.71	$41.85	$42.25	$43.32	$44.03
Tangible Book Value per Share	($10.59)	($11.09)	($12.06)	($12.80)	($12.58)	($19.51)	($18.30)	($17.81)	($18.57)	($26.76)	($26.12)
Total Capital	2,929	2,898	2,843	2,809	2,810	3,121	3,039	2,999	2,973	3,251	3,243
Total Debt	1,037	1,036	1,035	1,034	1,034	1,327	1,212	1,166	1,169	1,462	1,438
Total Long-Term Debt	1,037	1,036	1,035	1,034	1,034	1,327	1,212	1,166	1,169	1,462	1,438
Net Debt	861	878	903	868	828	1,220	1,073	1,039	1,008	1,319	1,285
Capital Expenditures (CapEx)	7.20	11	5.30	7.90	11	10	9.10	12	8.60	9.40	5.90
Debt-free, Cash-free Net Working Capital (DFCFNWC)	403	403	392	337	345	401	343	330	331	365	370
Debt-free Net Working Capital (DFNWC)	579	562	524	504	551	508	482	456	492	508	523
Net Working Capital (NWC)	579	562	524	504	551	508	482	456	492	508	523
Net Nonoperating Expense (NNE)	13	13	12	12	11	10	13	13	11	8.87	14
Net Nonoperating Obligations (NNO)	861	878	903	868	828	1,259	1,073	1,039	1,008	1,319	1,285
Total Depreciation and Amortization (D&A)	26	25	25	23	24	26	29	29	30	28	31
Debt-free, Cash-free Net Working Capital to Revenue	9.06%	9.23%	9.16%	8.05%	8.43%	9.98%	8.56%	8.27%	8.31%	9.16%	9.34%
Debt-free Net Working Capital to Revenue	13.01%	12.85%	12.25%	12.02%	13.43%	12.64%	12.03%	11.44%	12.36%	12.77%	13.19%
Net Working Capital to Revenue	13.01%	12.85%	12.25%	12.02%	13.43%	12.64%	12.03%	11.44%	12.36%	12.77%	13.19%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.08	$0.82	$1.03	$1.07	$0.96	$0.48	$0.67	$0.88	$0.59	$0.13	$0.35
Adjusted Weighted Average Basic Shares Outstanding	48.30M	46.50M	45.70M	44.50M	45.20M	43.70M	43.80M	43.50M	43.40M	41.30M	41M
Adjusted Diluted Earnings per Share	$1.06	$0.81	$1.02	$1.06	$0.94	$0.48	$0.67	$0.87	$0.58	$0.13	$0.35
Adjusted Weighted Average Diluted Shares Outstanding	48.70M	46.90M	46.10M	45M	45.70M	44M	44M	43.70M	43.60M	41.40M	41M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	46.50M	45.90M	44.80M	44.20M	43.60M	43.80M	43.80M	42.70M	41.30M	41M	41M
Normalized Net Operating Profit after Tax (NOPAT)	63	51	59	60	53	31	42	51	36	14	28
Normalized NOPAT Margin	5.86%	4.83%	5.68%	5.78%	5.39%	3.22%	4.13%	5.07%	3.66%	1.48%	2.80%
Pre Tax Income Margin	6.21%	5.08%	6.24%	6.10%	6.02%	3.22%	4.06%	4.99%	4.03%	1.09%	2.06%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.99	4.03	5.09	4.93	4.98	3.03	3.27	3.90	3.37	1.62	2.01
NOPAT to Interest Expense	3.77	2.88	3.72	3.72	3.56	2.03	2.32	2.94	2.15	0.84	1.38
EBIT Less CapEx to Interest Expense	4.56	3.41	4.75	4.44	4.22	2.36	2.77	3.22	2.85	1.07	1.73
NOPAT Less CapEx to Interest Expense	3.34	2.27	3.38	3.23	2.80	1.36	1.82	2.26	1.63	0.29	1.09
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	124.53%	146.22%	181.74%	195.90%	186.76%	188.54%	142.33%	114.61%	149.87%	161.77%	193.61%

Financials Breakdown Chart

Key Financial Trends

ASGN’s latest quarter shows a mixed but resilient picture: revenue held roughly flat year over year, profitability declined sharply from the prior-year period, and the company used financing and acquisitions to support growth. Cash generation remains positive, but leverage and acquisition-related goodwill/intangible assets are now a much bigger part of the balance sheet.

Operating cash flow remained positive at $18.5 million in Q1 2026, showing the business still generates cash despite lower earnings.
Gross margin improved slightly year over year in Q1 2026, with gross profit of $266.6 million on revenue of $968.3 million, versus a somewhat lower margin in Q1 2025.
The company continued to produce positive net income, with $4.8 million attributable to common shareholders in Q1 2026.
ASGN still has a sizable equity base, with $1.79 billion in total common equity at March 31, 2026.
Revenue in Q1 2026 was still near the $1 billion mark, indicating the company retains a large operating footprint.
Q1 2026 revenue of $968.3 million was down modestly from $980.1 million in Q4 2025 and $968.3 million in Q1 2025, suggesting relatively stable top-line trends lately.
Operating income fell to $27.7 million in Q1 2026 from $56.2 million in Q4 2025 and $46.6 million in Q1 2025, reflecting a weaker margin profile.
The company’s cash balance was $143.6 million at quarter-end, down from $126.5 million in Q3 2025 and $138.9 million in Q2 2025, but still workable.
ASGN’s balance sheet continues to carry heavy goodwill and intangibles, totaling more than $2.89 billion, which means a large portion of assets is not hard tangible value.
Share count has been drifting lower and higher across periods, but dilution is still visible from equity issuance and acquisition activity.
Net income dropped sharply year over year, from $25.2 million in Q4 2025 and $20.9 million in Q1 2025 to just $5.5 million in Q1 2026.
Free cash flow pressure is evident: Q1 2026 included $293 million of investing outflows, driven mainly by $283.6 million in acquisitions.
Long-term debt increased to $1.462 billion in Q1 2026 from $1.1657 billion in Q3 2025, increasing financial risk.
Cash and equivalents remain small relative to debt, and total liabilities of $2.239 billion keep leverage elevated.
In Q1 2026, financing activity relied on $350 million of new debt issuance while the company also repurchased stock, a capital structure mix that can support growth but also adds balance-sheet risk.

Longer-term trend: over the last four years, ASGN has generally produced solid revenue around the $1 billion quarterly level, but profitability has become more volatile. The company’s biggest shift has been on the balance sheet: debt has risen materially, and acquisitions have pushed goodwill and intangible assets much higher. That can work well if acquired businesses perform, but it also raises the stakes if margins weaken or integration slows.

Bottom line: ASGN still looks like a cash-generating business with a large revenue base, but near-term earnings momentum has cooled and leverage has climbed. Investors will likely want to watch whether operating margins stabilize and whether recent acquisitions begin to contribute enough to justify the added debt.

08/10/26 09:38 AM ETAI Generated. May Contain Errors.

ASGN Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ASGN's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

ASGN's net income appears to be on an upward trend, with a most recent value of $113.50 million in 2025, rising from $97.65 million in 2015. The previous period was $175.20 million in 2024. View ASGN's forecast to see where analysts expect ASGN to go next.

ASGN's total operating income in 2025 was $230.30 million, based on the following breakdown:

Total Gross Profit: $1.15 billion
Total Operating Expenses: $918.80 million

Over the last 10 years, ASGN's total revenue changed from $2.07 billion in 2015 to $3.98 billion in 2025, a change of 92.8%.

ASGN's total liabilities were at $1.87 billion at the end of 2025, a 13.4% increase from 2024, and a 90.7% increase since 2015.

In the past 10 years, ASGN's cash and equivalents has ranged from $0.00 in 2016 to $529.60 million in 2021, and is currently $161.20 million as of their latest financial filing in 2025.

Over the last 10 years, ASGN's book value per share changed from 14.86 in 2015 to 42.25 in 2025, a change of 184.2%.

Related Companies

Financial statements for NYSE:EFOR last updated on 7/31/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ASGN (EFOR) Financials

Financials Breakdown Chart

Key Financial Trends

ASGN Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ASGN (EFOR) Financials

Annual Income Statements for ASGN

Quarterly Income Statements for ASGN

Annual Cash Flow Statements for ASGN

Quarterly Cash Flow Statements for ASGN

Annual Balance Sheets for ASGN

Quarterly Balance Sheets for ASGN

Annual Metrics And Ratios for ASGN

Quarterly Metrics And Ratios for ASGN

Financials Breakdown Chart

Key Financial Trends

ASGN Financials - Frequently Asked Questions

When does ASGN's fiscal year end?

How has ASGN's net income changed over the last 10 years?

What is ASGN's operating income?

How has ASGN's revenue changed over the last 10 years?

How much debt does ASGN have?

How much cash does ASGN have?

How has ASGN's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools